在瘤治疗中,M1巨细胞衍生的细胞外囊泡的进展
Houli Liu1, Zhaorong Ouyang1, Siyu Li1
1School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui Province 230012, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|December 7, 2024
概括
来自M1巨细胞 (M1 EVs) 的细胞外囊泡通过激活免疫细胞和向瘤,显示出对瘤治疗和药物输送的希望. 这些生物相容的囊泡可以通过各种方法封装治疗药物,为癌症治疗提供了一个有前途的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
背景情况:
- 经典激活的M1巨细胞产生细胞外囊泡 (M1 EVs),具有固有的治疗潜力.
- M1 EVs拥有独特的生物信使,能够在瘤微环境中激活免疫细胞.
- 这些EV因其瘤向性,生物相容性和无毒性特征而闻名,使其适合于药物输送.
研究的目的:
- 综合审查M1 EVs用于瘤治疗的应用方面的进展.
- 讨论使用M1电动车在癌症治疗和药物输送中的前景和挑战.
主要方法:
- 用诸如电穿孔,共化,超声波,挤出,转染和点击化学等方法将治疗性货物封装到M1 EV中.
- 在临床前和临床环境中对M1 EV应用的现有文献的审查.
主要成果:
- M1 EVs在激活对瘤的免疫反应方面表现出显著的潜力.
- 它们固有的瘤定位能力提高了药物输送效率.
- 对于M1电动汽车,已经建立了各种货物装载技术.
结论:
- M1 EVs代表了开发新型癌症免疫疗法和向药物递送系统的有前途平台.
- 需要进一步的研究来应对现有的挑战,并优化基于M1 EV的治疗策略.
- 该审查强调了M1 EVs在瘤学中的广泛应用前景.
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
01:38Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K